235 related articles for article (PubMed ID: 22504654)
1. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.
Kamath AT; Mastelic B; Christensen D; Rochat AF; Agger EM; Pinschewer DD; Andersen P; Lambert PH; Siegrist CA
J Immunol; 2012 May; 188(10):4828-37. PubMed ID: 22504654
[TBL] [Abstract][Full Text] [Related]
2. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant.
Kamath AT; Rochat AF; Valenti MP; Agger EM; Lingnau K; Andersen P; Lambert PH; Siegrist CA
PLoS One; 2008; 3(11):e3683. PubMed ID: 18997860
[TBL] [Abstract][Full Text] [Related]
3. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells.
Tae YM; Park HT; Moon HG; Kim YS; Jeon SG; Roh TY; Bae YS; Gho YS; Ryu SH; Kwon HS; Kim YK
J Immunol; 2012 Feb; 188(4):1799-808. PubMed ID: 22262660
[TBL] [Abstract][Full Text] [Related]
4. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
5. A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.
Kamath AT; Rochat AF; Christensen D; Agger EM; Andersen P; Lambert PH; Siegrist CA
PLoS One; 2009 Jun; 4(6):e5771. PubMed ID: 19492047
[TBL] [Abstract][Full Text] [Related]
6. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Kamath AT; Valenti MP; Rochat AF; Agger EM; Lingnau K; von Gabain A; Andersen P; Lambert PH; Siegrist CA
Eur J Immunol; 2008 May; 38(5):1247-56. PubMed ID: 18412160
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
[TBL] [Abstract][Full Text] [Related]
8. Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs.
Meza-Sánchez D; Pérez-Montesinos G; Sánchez-García J; Moreno J; Bonifaz LC
Eur J Immunol; 2011 Oct; 41(10):2894-904. PubMed ID: 21792876
[TBL] [Abstract][Full Text] [Related]
9. Exposure to nicotine adversely affects the dendritic cell system and compromises host response to vaccination.
Nouri-Shirazi M; Guinet E
J Immunol; 2012 Mar; 188(5):2359-70. PubMed ID: 22279108
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA
Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826
[TBL] [Abstract][Full Text] [Related]
11. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.
Taylor PR; Koski GK; Paustian CC; Bailey E; Cohen PA; Moore FB; Zimmerman DH; Rosenthal KS
Vaccine; 2010 Aug; 28(34):5533-42. PubMed ID: 20600501
[TBL] [Abstract][Full Text] [Related]
12. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
[TBL] [Abstract][Full Text] [Related]
13. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
14. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J
J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823
[TBL] [Abstract][Full Text] [Related]
15. Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
Ebensen T; Libanova R; Schulze K; Yevsa T; Morr M; Guzmán CA
Vaccine; 2011 Jul; 29(32):5210-20. PubMed ID: 21619907
[TBL] [Abstract][Full Text] [Related]
16. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
[TBL] [Abstract][Full Text] [Related]
17. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
[TBL] [Abstract][Full Text] [Related]
18. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
Degermann S; Pria E; Adorini L
J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
[TBL] [Abstract][Full Text] [Related]
19. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.
van Dissel JT; Joosten SA; Hoff ST; Soonawala D; Prins C; Hokey DA; O'Dee DM; Graves A; Thierry-Carstensen B; Andreasen LV; Ruhwald M; de Visser AW; Agger EM; Ottenhoff TH; Kromann I; Andersen P
Vaccine; 2014 Dec; 32(52):7098-107. PubMed ID: 25454872
[TBL] [Abstract][Full Text] [Related]
20. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
